Logo

PierianDx

PierianDx Closes Equity Financing, Loan Facility for up to $47.5M

OrbiMed was the lead investor in the new financing, which is expected to drive PierianDx's commercial expansion. The firm raised $27 million in 2019.

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients

The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

PierianDx will integrate its cancer profiling assays with Pillar Biosciences' PiVAT bioinformatics pipeline on a GPDR-compliant platform.

May 5, 2020

PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market

Oct 28, 2019

PierianDx Raises $27M in Series B Round

Jul 1, 2019

MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles
Premium

Mar 12, 2019

Forensic Genomics Firm Othram Raises $4M

Feb 14, 2019

Q&A: Andreessen Horowitz's Jorge Conde Discusses Power of Meshing Biology and Engineering
Premium

Jan 4, 2019

Illumina, PierianDx to Collaborate on Cancer Sequencing Assays

Jun 1, 2018

2bPrecise, PierianDx to Develop Point-of-Care Technology for Precision Medicine

May 15, 2018

PierianDx Partners With ScienceVision to Bring Clinical Genomics Platform to Asia

Apr 17, 2018

RTI, PierianDx Collaborate on Clinical Genomics Platform

Mar 14, 2018

PierianDx, Cancer Genetics Partner on Precision Cancer Medicine Offering

Feb 13, 2018

PierianDx Raises $3M in New Funding, Seeks $2M More

Mar 10, 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point
Premium

Nov 2, 2015

Acquisition of Knome Assets Expands Tute Interpretation Toolkit
Premium

Nov 2, 2015

Tute Genomics Acquires Knome

Jan 12, 2015

Genalice, Knome to Jointly Offer NGS Analysis Solutions

Oct 1, 2014

Swiss Foundation Taps Genalice, Knome for Rare Disease Research

Sep 23, 2014

Knome Joins the Global Alliance for Genomics and Health

Sep 9, 2014

Knome Providing NGS Data Interpretation Solution to LabCentral Startups for Free

Aug 15, 2014

Downloads and Upgrades: IMPROVER COPD Models and KnoSys 3.0
Premium

Apr 18, 2014

People in the News: Josh Forsythe and Mark Pottle
Premium

Breaking News
The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.